ArticleBMC medical genomics2026
Prenatal phenotypic delineation of a de novo EYA1 likely pathogenic variant in branchio-oto-renal syndrome.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundBranchio-oto-renal (BOR; MIM 113650) syndrome is primarily linked to pathogenic variants in the EYA1 gene. Although over 200 pathogenic variants of the EYA1 gene have been reported, validation of the pathogenicity of novel variants and the aggregation of prenatal phenotypes are crucial to guide prenatal diagnosis.
methodsThis study analyzed the clinical and genetic data of a fetus presenting with BOR syndrome. A de novo EYA1 gene variant was identified and the functional impact of this variant was validated using minigene splicing assays in vitro. Additionally, a systematic review of prenatal cases with EYA1 variants was conducted to summarize phenotypic frequencies.
resultsPrenatal ultrasound detected left ear anomaly, facial cyst and a persistent right umbilical vein. Genetic testing revealed a novel variant c.640-15G > A in the EYA1 gene. In vitro minigene assays demonstrated an aberrant effect on splicing. According to the American College of Medical Genetics (ACMG) guidelines, this variant was reclassified as likely pathogenic. Systematic literature review indicated that urinary system abnormalities and amniotic fluid anomalies were more prevalent in prenatal cases.
conclusionsThis study adds a novel likely pathogenic variant to the EYA1 variant spectrum in BOR syndrome and suggests that certain prenatal ultrasound phenotypic markers might be strongly associated with EYA1-related diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.